Study Evaluating the Safety, Efficacy and Pharmacokinetics of SYH9089 Injection in Patients Undergoing Abdominal Surgery.

NCT07519109 · clinicaltrials.gov ↗

PHASE1

Phase

NOT_YET_RECRUITING

Status

60

Enrollment

INDUSTRY

Sponsor class

Conditions

Postoperative Pain

Interventions

DRUG: SYH9089 injection
DRUG: Ropivacaine hydrochloride
DRUG: 0.9 % sodium chloride

Sponsor

CSPC Ouyi Pharmaceutical Co., Ltd.